Compendium of Cancer Genome Aberrations

PEDS5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
← Older edit
VisualWikitext
No edit summary
No edit summary
 
(11 intermediate revisions by the same user not shown)
Line 6: Line 6:


To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
__TOC__
{| class="wikitable" style="margin:auto"
{| class="wikitable" style="margin:auto"
|+<big>WHO Classification of Paediatric Tumours (5th Edition) Content</big>
|+<big>WHO Classification of Paediatric Tumours (5th Edition) Content</big>
Line 16: Line 18:
!'''Date of Last Editor Review'''
!'''Date of Last Editor Review'''
!'''Notes'''
!'''Notes'''
|-
|
==== CHAPTER 2 (HAEMATOLYMPHOID DISORDERS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|-
|[[PEDS5:Chronic_myeloid_leukaemia_(CML)|Chronic myeloid leukaemia (CML)]]
|[[PEDS5:Chronic_myeloid_leukaemia_(CML)|Chronic myeloid leukaemia (CML)]]
Line 434: Line 457:
|
|
|
|
|-
|
==== CHAPTER 3 (CNS TUMOURS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|-
|[[PEDS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
|[[PEDS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
Line 940: Line 984:
|
|
|
|
|-
|
==== CHAPTER 4 (PERIPHERAL NEUROBLASTIC TUMOURS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|-
|[[PEDS5:Ganglioneuroma|Ganglioneuroma]]
|[[PEDS5:Ganglioneuroma|Ganglioneuroma]]
Line 985: Line 1,050:
|
|
|-
|-
|[[PEDS5:Epibulbar_choristoma|Epibulbar choristoma]]
|Disease
|
|
==== CHAPTER 5 (EYE TUMOURS) ====
|
----
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|[[PEDS5:Epibulbar_osseous_choristoma|Epibulbar osseous choristoma]]
|[[PEDS5:Epibulbar_choristoma|Epibulbar choristoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[PEDS5:Epibulbar_osseous_choristoma|Epibulbar osseous choristoma]]
|Disease
|Disease
|
|
Line 1,105: Line 1,191:
|
|
|
|
|-
|
==== CHAPTER 6 (SOFT TISSUE AND BONE TUMOURS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|-
|[[PEDS5:Lipomatosis|Lipomatosis]]
|[[PEDS5:Lipomatosis|Lipomatosis]]
Line 2,172: Line 2,279:
|
|
|
|
|-
|
==== CHAPTER 7 (GERM CELL TUMOURS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|-
|[[PEDS5:Intratubular_germ_cell_neoplasia_(male_gonadal)|Intratubular germ cell neoplasia (male gonadal)]]
|[[PEDS5:Intratubular_germ_cell_neoplasia_(male_gonadal)|Intratubular germ cell neoplasia (male gonadal)]]
Line 2,327: Line 2,455:
|
|
|-
|-
|[[PEDS5:Paediatric_cystic_nephroma|Paediatric cystic nephroma]]
|Disease
|
|
==== CHAPTER 8 (RENAL AND MALE GENITAL TUMOURS) ====
|
----
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|[[PEDS5:Nephroblastoma|Nephroblastoma]]
|[[PEDS5:Paediatric_cystic_nephroma|Paediatric cystic nephroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[PEDS5:Nephroblastoma|Nephroblastoma]]
|Disease
|Disease
|
|
Line 2,502: Line 2,651:
|
|
|
|
|-
|
==== CHAPTER 9 (FEMALE GENITAL TUMOURS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|-
|[[PEDS5:Ovarian_fibroma|Ovarian fibroma]]
|[[PEDS5:Ovarian_fibroma|Ovarian fibroma]]
Line 2,635: Line 2,805:
|
|
|-
|-
|[[PEDS5:Fibroepithelial_tumours_|Fibroepithelial tumours]]
|Disease
|
|
==== CHAPTER 10 (BREAST TUMOURS) ====
|
----
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|[[PEDS5:Juvenile_fibroadenoma|Juvenile fibroadenoma]]
|[[PEDS5:Fibroepithelial_tumours_|Fibroepithelial tumours]]
|Disease
|Disease
|
|
Line 2,657: Line 2,837:
|
|
|-
|-
|[[PEDS5:Juvenile_papillomatosis|Juvenile papillomatosis]]
|[[PEDS5:Juvenile_fibroadenoma|Juvenile fibroadenoma]]
|Disease
|Disease
|
|
Line 2,668: Line 2,848:
|
|
|-
|-
|[[PEDS5:Hepatoblastoma|Hepatoblastoma]]
|[[PEDS5:Juvenile_papillomatosis|Juvenile papillomatosis]]
|Disease
|Disease
|
|
Line 2,679: Line 2,859:
|
|
|-
|-
|[[PEDS5:Fibrolamellar_variant_of_hepatocellular_carcinoma|Fibrolamellar variant of hepatocellular carcinoma]]
|Disease
|
|
==== CHAPTER 11 (DIGESTIVE SYSTEM TUMOURS) ====
|
----
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|[[PEDS5:Paediatric_hepatocellular_carcinoma|Paediatric hepatocellular carcinoma]]
|[[PEDS5:Hepatoblastoma|Hepatoblastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[PEDS5:Fibrolamellar_variant_of_hepatocellular_carcinoma|Fibrolamellar variant of hepatocellular carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[PEDS5:Paediatric_hepatocellular_carcinoma|Paediatric hepatocellular carcinoma]]
|Disease
|Disease
|
|
Line 2,821: Line 3,033:
|
|
|
|
|-
|
==== CHAPTER 12 (ENDOCRINE TUMOURS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|-
|[[PEDS5:Follicular_adenoma_of_the_thyroid|Follicular adenoma of the thyroid]]
|[[PEDS5:Follicular_adenoma_of_the_thyroid|Follicular adenoma of the thyroid]]
Line 2,943: Line 3,176:
|
|
|-
|-
|[[PEDS5:Squamous_cell_papilloma_of_the_larynx|Squamous cell papilloma of the larynx]]
|Disease
|
|
==== CHAPTER 13 (HEAD AND NECK TUMOURS) ====
|
----
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|[[PEDS5:White_sponge_naevus|White sponge naevus]]
|[[PEDS5:Squamous_cell_papilloma_of_the_larynx|Squamous cell papilloma of the larynx]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[PEDS5:White_sponge_naevus|White sponge naevus]]
|Disease
|Disease
|
|
Line 3,129: Line 3,383:
|
|
|
|
|-
|
==== CHAPTER 14 (THORACIC TUMOURS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|-
|[[PEDS5:Fetal_lung_interstitial_tumour|Fetal lung interstitial tumour]]
|[[PEDS5:Fetal_lung_interstitial_tumour|Fetal lung interstitial tumour]]
Line 3,173: Line 3,448:
|
|
|
|
|-
|
==== CHAPTER 15 (SKIN TUMOURS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|-
|[[PEDS5:Hamartomas|Hamartomas]]
|[[PEDS5:Hamartomas|Hamartomas]]
Line 3,284: Line 3,580:
|
|
|-
|-
|[[PEDS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|Disease
|
|
==== CHAPTER 16 (GENETIC TUMOUR SYNDROMES) ====
|
----
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|[[PEDS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|-
|[[PEDS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
|[[PEDS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[PEDS5:Tuberous_sclerosis|Tuberous sclerosis]]
|[[PEDS5:Tuberous_sclerosis|Tuberous sclerosis]]
Line 3,341: Line 3,658:
|[[PEDS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
|[[PEDS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[PEDS5:Hereditary_phaeochromocytoma-paraganglioma_syndromes|Hereditary phaeochromocytoma-paraganglioma syndromes]]
|[[PEDS5:Hereditary_phaeochromocytoma-paraganglioma_syndromes|Hereditary phaeochromocytoma-paraganglioma syndromes]]
Line 3,363: Line 3,680:
|[[PEDS5:WAGR_syndrome|WAGR syndrome]]
|[[PEDS5:WAGR_syndrome|WAGR syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[PEDS5:Beckwith-Wiedemann_and_related_overgrowth_syndromes|Beckwith-Wiedemann and related overgrowth syndromes]]
|[[PEDS5:Beckwith-Wiedemann_and_related_overgrowth_syndromes|Beckwith-Wiedemann and related overgrowth syndromes]]
Line 3,385: Line 3,702:
|[[PEDS5:Familial_adenomatous_polyposis|Familial adenomatous polyposis]]
|[[PEDS5:Familial_adenomatous_polyposis|Familial adenomatous polyposis]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[PEDS5:Lynch_syndrome|Lynch syndrome]]
|[[PEDS5:Lynch_syndrome|Lynch syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[PEDS5:Xeroderma_pigmentosum|Xeroderma pigmentosum]]
|[[PEDS5:Xeroderma_pigmentosum|Xeroderma pigmentosum]]
Line 3,429: Line 3,746:
|[[PEDS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|[[PEDS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[PEDS5:DICER1_syndrome|DICER1 syndrome]]
|[[PEDS5:DICER1_syndrome|DICER1 syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[PEDS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
|[[PEDS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
Line 3,462: Line 3,779:
|[[PEDS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
|[[PEDS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[PEDS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
|[[PEDS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
Retrieved from "https://test.ccga.io/index.php/PEDS5:Volunteer_Assignments_and_Opportunities"